References
- Restriction IG. ACOG Practice Bulletin No. 12. Washington, DC: American College of Obstetricians and Gynecologists; 2000
- Suhag A, Berghella V. Intrauterine growth restriction (IUGR): etiology and diagnosis. Curr Obstet Gynecol Rep 2013;2:102–11
- Reeves S, Galan HL. Fetal growth restriction. In: Berghella V, ed. Maternal-fetal evidence-based guidelines. 2nd ed. London: Informa Health Care; 2012:329–44
- Sankaran S, Kyle PM. Aetiology and pathogenesis of IUGR. Best Pract Res Clin Obstet Gynaecol 2009;23:765–77
- Karowicz-Bilinska A, Kędziora-Kornatowska K, Bartosz G. Indices of oxidative stress in pregnancy with fetal growth restriction. Free Radic Res 2007;41:870–3
- Biondi C, Pavan B, Lunghi L, et al. The role and modulation of the oxidative balance in pregnancy. Curr Pharm Design 2005;11:2075–89
- Agarwal A, Gupta S, Sikka S. The role of free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol 2006;18:325–32
- Takagi Y, Nikaido T Toki T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004;444:49–55
- Karowicz-Bilinska A, Marszalek M, Kowalska-Koprek U, et al. Plasma carbonyl group concentration in pregnant women with IUGR treated by l-arginine and acetylsalicylic acid. Ginekol Pol 2004;75:15–20
- Karowicz-Bilinska A. Lipid peroxides concentration in women with intrauterine growth restriction. Ginekol Pol 2004;75:6–9
- Kim YJ, Hong YC, Lee K, et al. Oxidative stress in pregnant women and birth weight reduction. Reprod Toxicol 2005;19:487–92
- Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol 2011;25:287–99
- Alwarfaly S, Abdulsid A, Hanretty K, et al. Paraoxonase 2 protein is spatially expressed in the human placenta and selectively reduced in labour. PLoS One 2104;9:e96754
- Précourt LP, Amre D, Denis MC, et al. The three-gene paraoxonase family: physiologic roles, actions, and regulation. Atherosclerosis 2011;214:20–36
- Belteki G, Kempster SL, Forhead AJ, et al. Paraoxonase-3, a putative circulating antioxidant, is systemically up-regulated in late gestation in the fetal rat, sheep, and human. J Clin Endocrinol Metab 2010;95:3798–805
- Gagnon R. Placental insufficiency and its consequences. Eur J Obstet Reprod Biol 2003;110:S99–107
- Longini M, Perrone S, Kenanidis A, et al. Isoprostanes in amniotic fluid: a predictive marker for fetal growth restriction in pregnancy. Free Radic Biol Med 2005;38:1537–41
- Kimura C, Watanabe K, Iwasaki A, et al. The severity of hypoxic changes and oxidative DNA damage in the placenta of early-onset preeclamptic women and fetal growth restriction. J Matern Fetal Neonatal Med 2013;26:491–6
- Yung HW, Calabrese S, Hynx D, et al. Evidence of placental translation inhibition and endoplasmic reticulum stress in the etiology of human intrauterine growth restriction. Am J Pathol 2008;173:451–62
- Min J, Park H, Park B, et al. Paraoxonase gene polymorphism and vitamin levels during pregnancy: relationship with maternal oxidative stress and neonatal birthweights. Reprod Toxicol 2006;22:418–24
- Cindrova-Davies T, Yung HW, Johns J, et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am J Pathol 2007;171:1168–79
- Espinoza J, Sebire NJ, McAuliffe F, et al. Placental villus morphology in relation to maternal hypoxia at high altitude. Placenta 2001;22:606–8
- Burton GJ. Oxygen, the Janus gas; its effects on human placental development and function. J Anat 2009;215:27–35
- Mackness B, Beltran‐Debon R, Aragones G, et al. Human tissue distribution of paraoxonases 1 and 2 mRNA. IUBMB Life 2010;62:480–2